Two-pore segment channel 2 (TPC2) is a ubiquitously expressed, lysosomally targeted ion channel that aids in terminating autophagy and is inhibited upon its association with mechanistic target of rapamycin (mTOR 
INTRODUCTION
The two-pore segment channels (TPCs) (1) are nicotinic acid adenine dinucleotide phosphate (NAADP)-gated Ca 2+ release channels that are targeted to endolysosomes (2) (3) (4) (5) (6) (7) . Consistent with this view, TPC1, TPC2, and TPC3, of which only TPCN1 and TPCN2 genes (2, 8) are present in humans, rats, and mice, are homologous with and represent an evolutionary intermediate between some Ca 2+ -permeable transient receptor potential (TRP) channels and voltage-gated Ca 2+ channels, with an intermediate two-domain structure of subunits that likely assemble as homodimers (2, 8) . However, controversy surrounds the capacity of TPC2 to support an NAADP-gated Ca 2+ conductance, given that others have demonstrated that human TPC2 expressed in several different mammalian cell types is highly selective for Na + and carries a Na + conductance in response to phosphatidylinositol 3,5-bisphosphate [PI(3,5)P 2 ] but not NAADP (7, 9, 10) . Countering this notion, cells derived from Tpcn1 and Tpcn2 null mice generate PI(3,5)P 2 -mediated cation currents but not NAADP-gated Ca 2+ currents, and NAADPdependent cation currents are restored in Tpcn1 and Tpcn2 null cells by overexpression of wild-type TPC2 (11) . That said, it is clear that TPC2 mediates a Na + conductance that is inhibited by mechanistic target of rapamycin (mTOR) (10) and TPC2 contributes to autophagy termination by facilitating mTOR reactivation (12) . Activation of mTOR complex 1 (mTORC1) has been implicated in the progression of diseases such as pulmonary hypertension for which current therapies are ineffective (13) . Therefore, we sought to determine whether TPC2 mediates lysosomal Ca 2+ signals in pulmonary arterial myocytes upon intracellular dialysis of NAADP and PI(3,5)P 2 , respectively, and the role of mTOR in these processes.
RESULTS

TPC2 deletion in pulmonary arterial myocytes abolishes global Ca
2+ waves in response to NAADP but not PI(3,5)P 2 , inositol 1,4,5-trisphosphate, or cyclic adenosine 5′-diphosphoribose We examined the action of various Ca 2+ mobilizing messengers in pulmonary arterial myocytes prepared from wild-type mice and Tpcn2 knockout mice (2, 12) by using intracellular dialysis from a patch pipette under voltage clamp, with the holding potential set to −40 mV to inactivate voltage-gated Ca 2+ channels. Intracellular dialysis of NAADP induced global Ca 2+ waves in acutely isolated pulmonary arterial myocytes from wild-type mice (Fig. 1A) . By contrast, NAADP did not induce a measurable Ca 2+ transient in paired experiments on myocytes derived from Tpcn2 knockout mice (Fig. 1A) , as assessed by the Fura-2 F 340 /F 380 ratio. In contrast, the response to intracellular dialysis of either PI(3,5)P 2 , inositol 1,4,5-trisphosphate [(1,4,5)P 3 ], or cyclic adenosine 5′-diphosphoribose (cADPR) was similar in myocytes derived from Tpcn2 knockout mice when compared to wild-type cells (Fig. 1, B 
to E).
Consistent with our previous studies on rat pulmonary arterial myocytes (14) , the response of mouse myocytes to NAADP was abolished by depletion of acidic Ca 2+ stores with bafilomycin-A1 ( Fig. 1F ) and attenuated after depletion of sarcoplasmic reticulum (SR) Ca 2+ stores by preincubation with the SR Ca 2+ adenosine triphosphatase (ATPase) inhibitor thapsigargin (Fig. 1G) (Fig. 2, A and B ) and in human embryonic kidney (HEK) 293 cells stably overexpressing hTPC2 (Fig. 2C ) to comparable extents (Fig. 2D) . These results are consistent with verapamil blocking the Na + conductance carried by hTPC2 (9) . From these data, we conclude that irrespective of the continued presence of releasable, acidic Ca 2+ stores, TPC1, functional ryanodine receptors, and I(1,4,5)P 3 receptors, TPC2 is required for the induction of global Ca 2+ signals by NAADP but by contrast is not necessary for Ca 2+ signaling by PI(3,5)P 2 , I(1,4,5)P 3 , or cADPR, at least in the cell types studied here. Consistent with this view, double-blind paired analysis showed that intracellular dialysis of NAADP induced Ca 2+ transients in HEK293 cells that stably overexpressed enhanced green fluorescent protein (EGFP)-tagged hTPC2 but not in those expressing its inactive mutant (N653K) that does not support Na + conductance (fig. S1, A and B). As previously reported (9), we found by direct electrophysiological measurements of isolated lysosomes that hTPC2 conferred a PI(3,5)P 2 -gated, NAADP-insensitive Na + conductance. However, in the presence of high luminal and "cytoplasmic" Ca 2+ [60 mM in pipette, 200 M in bath, which reproduces previously used conditions (11)], TPC2 supported an NAADP-and PI(3,5)P 2 -sensitive Ca 2+ conductance in our hands ( fig. S2 , A to C and E), consistent with previous reports on the capacity of TPC2 to support a small (7), NAADP-sensitive Ca 2+ conductance (11) .
Rapamycin induces Ca
2+ signals through acidic stores in an mTOR-and TPC2-dependent manner Extracellular application of rapamycin induced concentration-dependent Ca 2+ signals in hTPC2-expressing HEK293 cells (Fig. 3, A to E and H); by contrast, rapamycin induced small Ca 2+ transients in wild-type HEK293 cells (Fig. 3I) , which have low TPC2 abundance (2) . Rapamycin triggered Ca 2+ transients in hTPC2-expressing HEK293 cells at as low a concentration as 100 nM (Fig. 3A) . At the higher concentrations tested, rapamycin-evoked Ca 2+ transients were multiphasic, characterized by an initial large transient followed by Ca 2+ oscillations that were variable in number and magnitude, and all were superimposed upon what appeared to be a slower, more uniform, and prolonged Ca 2+ signal (Fig. 3I) . However, the concentration-response curve for rapamycin-induced Ca 2+ signals was bell-shaped, peaking at 30 M and exhibiting progressive levels of "desensitization" between 100 and 300 M, at which concentrations rapamycin-induced desensitization occurred without a detectable Ca 2+ signal being evoked (Fig. 3H) . These results are consistent with our previous reports on the nature of the response of these cells (20) and the response of pulmonary arterial myocytes (14) to NAADP. Although rapamycin inhibits mTORC1 at low concentrations, we found that at the high concentration that gave the peak response in the Ca 2+ assay (30 M), the drug decreased mTORC1 activity in HEK293 cells faster than at the lower concentrations (300 nM), as indicated by S6K phosphorylation (fig. S3, A and B). Therefore, 30 M rapamycin was used in all subsequent experiments to ensure robust and reproducible responses.
The response to 30 M rapamycin ( Fig. 3I ) was abolished by previous depletion of acidic Ca 2+ stores with bafilomycin-A1 ( Fig. 3J ) and attenuated by preincubation of cells with thapsigargin ( Fig. 3K) . Thapsigargin blocked the fast oscillating Ca 2+ transients but not the slow progressive rise in Ca 2+ on which these were superimposed, suggesting that the Ca 2+ oscillations likely result from Ca
release from the endoplasmic reticulum triggered by previous Ca 2+ release from acidic Ca 2+ stores. Furthermore, all signals were abolished by preincubation of cells with nifedipine ( Fig. 3L) . In pulmonary arterial myocytes, rapamycin induced Ca 2+ transients that were mostly biphasic, characterized by a single rapid, global Ca 2+ transient that was once again superimposed on an underlying slower transient (Fig. 3M) . Occasionally, the initial, fast Ca 2+ transient was followed by multiple smaller transients that were all superimposed on the slower underlying Ca 2+ signal as for HEK293 cells, but such Ca 2+ oscillations were not a common feature of the response to rapamycin for pulmonary arterial myocytes. In the myocytes, rapamycin-evoked Ca 2+ transients were blocked by previous depletion of acidic Ca 2+ stores with bafilomycin-A1 (Fig. 3N) , attenuated by preincubation with thapsigargin ( Fig. 3O) or ryanodine (Fig. 3O) , and abolished by preincubation with nifedipine ( Fig. 3P) . These results were similar to those obtained in HEK293 cells stably overexpressing hTPC2 and to that previously reported for NAADP-evoked Ca 2+ signals in pulmonary arterial myocytes (14) . Because of the more complex nature of rapamycin-induced Ca 2+ signals, from this point forward, we analyzed the responses for mTOR inhibition by measuring the "area under the curve" (AUC), which may provide a more accurate assessment of out comes (Fig. 4 , A and B). Consistent with previous findings of others for TPC2 (19) , rapamycin-and NAADP-induced Ca 2+ transients were also blocked by tetrandrine (Fig. 4 , C and D), which has previously been shown to activate autophagy (21) and block TPC2 (22) . Moreover, similar to rapamycin, the mTOR inhibitor torin-2 also evoked biphasic Ca 2+ transients in HEK293 cells stably overexpressing hTPC2 and in pulmonary arterial myocytes ( Neither rapamycin nor torin-2 induced measurable Ca 2+ transients in myocytes derived from Tpcn2 knockout mice (Fig. 5 , A to C). Moreover, short hairpin RNA (shRNA) knockdown of mTOR in HEK293 cells that stably overexpressed hTPC2 attenuated Ca 2+ transients induced by rapamycin and NAADP (Fig. 5, D and G) . These data suggest that rapamycin induces Ca 2+ transients in a TPC2-dependent manner by inhibiting mTOR, and TPC2 may therefore be the point of convergence for the induction of Ca 2+ signals by NAADP and mTOR inhibition. This notion was confirmed by cross-desensitization of signaling between mTOR inhibition and NAADP. NAADP-induced Ca 2+ signals were abolished by preincubation with rapamycin or torin-2 both in pulmonary arterial smooth muscle cells (PASMCs) (Fig. 6 , A to D) and in HEK293 cells that stably overexpressed hTPC2 (Fig. 6 , E and H). However, the effects of previous intracellular dialysis of high, desensitizing concentrations of NAADP on rapamycin-induced Ca 2+ signals were more variable but generally appeared to have little effect. In rat pulmonary arterial myocytes, after intracellular dialysis of NAADP, Ca 2+ transients evoked by rapamycin were marginally attenuated only when assessed by AUC, and these differences were not significant (Fig. 6, C and D) . Moreover, in hTPC2-HEK293 cells, previous intracellular dialysis of desensitizing concentrations of NAADP did not affect Ca 2+ transients (Fig. 6 , G and H). This contrary outcome may be due to disparities with respect to the amount of time in which pulmonary arterial myocytes and hTPC2-expressing HEK293 cells could be held in the whole-cell configuration and the time dependence of the process of desensitization by high concentrations of NAADP. Alternatively, NAADP may self-desensitize this macromolecular signaling complex at a point upstream of mTOR.
Rapamycin evokes bafilomycin-A1-and nifedipine-sensitive Ca
2+ signals proximal to TPC2 in HEK293 cells We next used HEK293 cells that stably overexpressed GCaMP5-hTPC2, in which the genetically encoded Ca 2+ indicator GCaMP5 was fused to the cytoplasmic N terminus of TPC2, allowing the detection of Ca 2+ signals arising near the lysosome-localized TPC2. Confocal imaging showed that GCaMP5-hTPC2 specifically labeled LysoTracker Red-positive vesicles, which formed either static clusters of variable density or smaller motile units (Fig. 7A) . Application of rapamycin induced slowly developing increases in fluorescence that arose and returned to baseline with a time course of 60 to 120 s (Fig. 7B) . These followed a similar time course to the slower, thapsigargininsensitive signals recorded by way of Fura-2 fluorescence ratio (Fig. 3K) . These findings suggest that the sampling interval (0.2 Hz) for confocal experiments did not provide the temporal resolution necessary to reveal those fast Ca 2+ transients superimposed on the slower, thapsigargin-insensitive components of rapamycin-induced signals described above. Consistent with this view, these signals were blocked by previous depletion of acidic stores by bafilomycin-A1 and by preincubation with nifedipine but were not affected by preincubation of cells with thapsigargin (Fig. 7, C to E) . Furthermore, nifedipine reduced basal fluctuations in GCaMP5-hTPC2 fluorescence relative to control, providing indirect support for the view that this L-type voltagegated Ca 2+ channel antagonist directly inhibits lysosomal Ca 2+ efflux, whether through TPC2 or a distinct pathway governed by activation of TPC2. 
DISCUSSION
Using fully differentiated, acutely isolated pulmonary arterial myocytes to examine the role of TPC2 in lysosomal Ca 2+ signaling (23-25) in combination with HEK293 cell lines stably overexpressing human TPC2, we showed that TPC2 was required for global Ca 2+ transients in response to intracellular dialysis of NAADP. Briefly, NAADP failed to induce global Ca 2+ transients in pulmonary arterial myocytes from Tpcn2 knockout mice although both lysosomes and the SR retained replete and releasable Ca 2+ stores, mobilization of the former being triggered by GPN and bafilomycin-A1 and the latter by intracellular dialysis of I(1,4,5)P 3 and cADPR. TPC1 (2), ryanodine receptors, and I(1,4,5)P 3 receptors remain available in pulmonary arterial myocytes (14, 20, (24) (25) (26) from Tpcn2 knockout mice, thereby demonstrating that TPC2 is required for the induction of global Ca 2+ waves by NAADP in this cell type (24, 25) .
These findings recapitulate our previous observations on HEK293 cells, which suggested that overexpression of hTPC2 is required to support NAADP-dependent global Ca 2+ signals (2, 20) and that recombinant expression of ryanodine receptors is required for cADPRinduced Ca 2+ transients (20) . These findings are consistent with the observation that HEK293 cells primarily rely on I(1,4,5)P 3 receptors to mediate global Ca 2+ signals, while exhibiting little or no endogenous functional expression of either TPCs (2) or ryanodine receptors (27) . On the other hand, these findings argue against the proposal that PI(3,5)P 2 -gated Ca 2+ signals arise in a TPC2-dependent manner in these cells, regardless of whether TPC2 itself supports a Na + -specific conductance (9) or both Ca 2+ and Na + conductances (11). This view was strengthened by our studies on HEK293 cells and pulmonary arterial myocytes, in which we found that PI(3,5)P 2 not only evoked Ca 2+ oscillations in HEK293 cells stably overexpressing hTPC2 and pulmonary arterial myocytes derived from wild-type mice, but that PI(3,5)P 2 also did so in pulmonary arterial myocytes from Tpcn2 null mice and in wild-type HEK293 cells, in which endogenous expression of TPC2 is too low to support NAADP-dependent global Ca 2+ signals (2, 20) . These outcomes are therefore consistent with the retention of PI(3,5)P 2 -gated cation currents in cells from Tpcn1 and Tpcn2 doubleknockout mice (11) . Accordingly, others have shown that PI(3,5)P 2 can gate various channel families other than TPCs, including TRPML1 and ryanodine receptors (28) (29) (30) . We cannot, how ever, rule out the possibility that PI(3,5)P 2 availability is required to support TPC2 activity.
We found that rapamycin and another mTOR inhibitor, torin-2, also induced Ca 2+ signals by mobilizing bafilomycin-A1-sensitive, acidic stores in a manner that was markedly attenuated by shRNA knockdown of mTOR and abolished by Tpcn2 deletion. These data suggest that mTOR inhibitors induce Ca 2+ release from lysosomes through TPC2 in an mTOR-dependent manner rather than by directly binding to TPC2, although we cannot rule out the possibility that some mTOR inhibitors may also directly activate TPC2; torin-1 appeared to have a distinct mode of activating TPC2 ( fig. S5, A to D) . Moreover, using HEK293 cells stably overexpressing GCaMP5-hTPC2, we showed that rapamycin increased lysosomal Ca 2+ flux proximal to hTPC2 itself. This finding is not inconsistent with the findings of others that suggest that mTOR is an endogenous inhibitor of PI(3,5)P 2 -gated Na + currents carried by TPC2 (10). Although small when compared to their estimated Na + permeability, it appears that endogenous TPC2 may support a Ca 2+ conductance sufficient to trigger global Ca 2+ signals due to amplification of lysosomal Ca 2+ bursts at lysosome-SR nanojunctions (23) (24) (25) , as has been suggested by computer simulations (23) and electrophysiological investigations on the ion selectivity conferred by the filter sequence of the human TPC2 channel pore (7) and whole-endolysosomal recordings for human TPC2 carried out with Ca 2+ as the major permeant ion by others (7) and us ( fig. S2, A to D) . This notion is supported by our demonstration of cross-desensitization between mTOR inhibitor and NAADP with respect to their capacity to evoke Ca 2+ signals both in pulmonary arterial myocytes and in HEK293 cells stably overexpressing hTPC2. This observation is consistent with the indirect activation of TPC2 by NAADP through associated proteins (31, 32) and may confirm the primary physiological role of TPC2, in that mTOR-dependent Ca 2+ mobilization may modulate the luminal pH of lysosomes (33, 34) and thus autophagic flux (12, 35) . We conclude that inactivation of mTOR is a major endogenous pathway for initiating lysosomal Ca 2+ release in HEK293 cells stably overexpressing hTPC2 and in pulmonary arterial myocytes. Thus, the mTORC1-TPC2 complex may act as the endogenous gatekeeper of lysosomal Ca 2+ flux, which may in turn affect autophagy termination (D) and (E), for the peak change in F 340 /F 380 ratio induced by NAADP and the peak change attained during the first transient recorded after rapamycin (C) and the area under the curve during the response to rapamycin (D). *P < 0.05, ***P < 0.001, ****P < 0.0001.
and mTOR reactivation (12) . Because mTORC1-dependent myocyte proliferation promotes the progression of pulmonary hypertension (13), for which current therapies are ineffective, TPC2 may be a potential therapeutic target in idiopathic pulmonary hypertension and pulmonary hypertension secondary to lysosomal dysfunction associated with Pompe and Gaucher diseases (36, 37) . In this respect, our demonstration that nifedipine attenuates basal, NAADP-and rapamycin-evoked lysosomal Ca 2+ release in a TPC2-dependent manner is notable, because this Ca 2+ channel antagonist is used in the treatment of pulmonary hypertension (38, 39) . [number of cells (n) indicated above bars]. *P < 0.05, **P < 0.01. A.U., arbitrary units; TG, thapsigargin.
of 10 MATERIALS AND METHODS
Preparation of PASMCs and HEK293 cell lines stably expressing human TPC2
Experiments were performed in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986. Single arterial smooth muscle cells were isolated from second-order branches (external diameter, ~1 mm) of the pulmonary artery. Briefly, the arteries were dissected from lungs of male wild-type (C57/Bl6) and Tpcn2 knockout mice (28 to 33 g) (2), or Wistar rats (250 to 300 g), and single cells were acutely isolated from pulmonary arterial smooth muscle from mouse or rat as previously described (24) and placed in low-Ca 2+ solution of the following composition: 135 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 0.5 mM NaH 2 PO 4 , 0.5 mM KH 2 PO, 15 mM NaHCO 3 , 0.16 mM CaCl 2 , 0.5 mM EDTA, 10 mM glucose, 10 mM taurine, and 10 mM Hepes (pH 7.4). For cell isolation, dissected arteries were transferred into fresh low-Ca 2+ solution containing papain (1 mg/ml), dithiothreitol (0.8 mg/ml), and bovine serum albumin (0.7 mg/ml) and incubated for 10 min at 37°C and gently triturated using a fire-polished glass pipette to obtain dispersed PASMCs. Acutely isolated PASMCs were then plated in a 35-mm cell-culture dish (FluoroDish, World Precision Instruments Inc.) and used within 24 hours. The HEK293 cell line stably expressing human TPC2 was also developed and cultured as previously described (2) . Site-directed mutagenesis was performed to generate a TPC2 N653K mutant that lacked a Na + conductance using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). The mutation was confirmed by DNA sequencing.
Ca
2+ imaging Cells were incubated for 30 min with 5 M Fura-2-AM in nominally Ca 2+ -free physiological salt solution (PSS) of the following composition: 130 mM NaCl, 5.2 mM KCl, 1 mM MgCl 2 , 10 mM glucose, and 10 mM Hepes (pH 7.45) in an experimental chamber that was then placed on a Leica DM IRB/E inverted microscope after washing with Ca 2+ containing 1.7 mM CaCl 2 , Fura-2-free PSS for at least 30 min before experimentation. PSS was of the following composition: 130 mM NaCl, 5.2 mM KCl, 1 mM MgCl 2 , 1.7 mM CaCl 2 , 10 mM glucose, and 10 mM Hepes (pH 7.45). Cytoplasmic Ca 2+ concentration was reported by Fura-2 fluorescence ratio (F 340 /F 380 excitation; emission, 510 nm). Emitted fluorescence was recorded at 22°C with a sampling frequency of 0.5 Hz using a Hamamatsu 4880 charge-coupled device camera and a Zeiss Fluar 40× [1.3 numerical aperture (NA)] oil immersion objective. Background subtraction was performed online. Analysis was completed using OpenLab imaging software (PerkinElmer). NAADP (10 nM) was applied intracellularly into single cells in the whole-cell configuration of the patch-clamp technique (voltage clamp mode; holding potential = −40 mV). The pipette solution contained 140 mM KCl, 10 mM Hepes, 1 mM MgCl 2 , and 5 M Fura-2 (free acid) (pH 7.4) nominally Ca 2+ -free (~100 nM). The seal resistance was ≥3 gigohms throughout each experiment. Series and pipette resistance were ≤10 and ≤3 megohms, respectively, as measured by an AxoPatch 200B Amplifier (Axon Instruments).
Confocal microscopy
The GCaMP5 fluorescence ratio (expressed as F/F 0 ; F 0 = GCaMP5 fluorescence intensity at 0 s; F x = fluorescence intensity at time x for given region of interest) was recorded at 22°C with a sampling frequency of 0.5 Hz, using a Nikon A1R+ confocal system and a Nikon Eclipse Ti inverted microscope with a Nikon Apo 40× S DIC N2 (1.25 NA) water immersion objective (Nikon Instruments Europe BV). Experiments were processed with ImageJ software (Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, imagej. nih.gov/ij/, 1997-2012).
Analysis of mTOR activities in response to rapamycin treatment by immunoblotting HEK293 cells were seeded in six-well plates at 40 to 50% confluence and cultured overnight to reach ~70% confluence. Rapamycin was diluted to final concentrations of 0.3 and 30 M in complete culture medium [Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum] and warmed to 37°C before being added to the cells. At desired times (1 to 60 min) after the addition of rapamycin, the medium was aspirated, and 200 l of 1× SDS sampling buffer [50 mM tris-HCl, 2% SDS, 10% glycerol, 1% -mercaptoethanol, 12.5 mM EDTA, and 0.02% bromophenol blue (pH 6.8)] was immediately added to cause cell lysis. Cell lysates were then collected into 1.5-ml Eppendorf tubes and sonicated for 15 s before boiling at 99°C for 5 min. Lysates were resolved in 7.5% tris-glycine SDSpolyacrylamide gel electrophoresis gel and analyzed using mouse antiphospho-S6K (Thr 389 ) (1:1000; Cell Signaling Technology, catalog no. 9206) and rabbit anti-S6K (1:1000; Cell Signaling Technology, catalog no. 9202) primary antibodies. DyLight 800 goat anti-mouse (1:5000; Invitrogen, catalog no. SA5-10176) and DyLight 680 goat anti-rabbit (1:5000; Invitrogen, catalog no. 21109) secondary antibodies were used to reveal signals, and blots were scanned with fluorescent immunoblot instruments and software by LI-COR Odyssey software images.
Whole-endolysosome patch-clamp experiments
Endolysosomal patch-clamp recordings were performed in isolated enlarged endolysosomes using a modified patch-clamp method (9, 11, 40) . HEK293 cells stably expressing TPC2-EGFP were treated with 1 M vacuolin-1 for 12 to 36 hours. Electrophysiological recordings were performed using an EPC10 USB acquisition system (HEKA). PATCHMASTER software (HEKA) was used to record and analyze data. Recording solutions followed either that by Ruas et al. (11) or that by Wang et al. (9) , which differ mainly in that the pipette solution was either Ca 2+ -rich (Na + -free) or Na + -rich, respectively. The Ca 2+ -rich pipette solution contained 70 mM K-methanesulfonate (MSA), 60 mM Ca-MSA, 1 mM MgCl 2 , and 10 mM Hepes (pH adjusted with MSA to 4.6 and mannitol used to adjust osmolarity); the bath solution contained 130 mM K-MSA, 0.2 mM Ca-MSA, and 10 mM Hepes (pH adjusted with KOH to 7.2). The Na + -rich pipette solution had 145 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM Hepes, 10 mM MES, and 10 mM glucose (pH adjusted with NaOH to 4.6); the bath solution contained 140 mM K-gluconate, 4 mM NaCl, 1 mM EGTA, 2 mM MgCl 2 , 0.39 mM CaCl 2 , and 20 mM Hepes (pH adjusted with KOH to 7.2; free [Ca 2+ ] = 100 nM). Briefly, an isolated pipette was used to slice the cell membrane and release endolysosomes labeled with EGFP fluorescence. Only one enlarged endolysosome vacuole was recorded from each coverslip. Then, a freshly polished recording pipette was used to form a gigaseal to the vacuole. ZAP pulses (fast pulses of −400 to −1000 mV in 50-to 100-ms durations) were used to establish the whole-endolysosome configuration. Capacitance transients were compensated automatically. The holding potential was set at 70 mV, and inside-out recording mode was used for data acquisition in which the inward currents were defined as currents flowing out of lysosomal lumen into the cytosol. Voltage ramps from −150 to +150 mV within 200 ms were applied every second. A 20-ms step to −150 mV and a 20-ms step to +150 mV were included at the beginning and end of each ramp, respectively. Currents at −150 mV were used for further analysis.
Data presentation and statistical analysis
Data are presented as means ± SEM for n experiments. Comparisons between groups were by Kruskal-Wallis test with Dunn's multiple comparison test and nonparametric unpaired t test. Probability values less than 0.05 were considered to be statistically significant.
Drugs and chemicals
Unless otherwise stated, all compounds were from Sigma-Aldrich.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/11/525/eaao5775/DC1 Fig. S1 . Blind experiments on active and null hTPC2 constructs demonstrate robustness of intracellular dialysis technique. cells stably overexpressing hTPC2 and in rat pulmonary arterial myocytes.
